COMBINED THROMBOXANE-A2 SYNTHETASE INHIBITION AND RECEPTOR BLOCKADE ARE EFFECTIVE IN PREVENTING SPONTANEOUS AND EPINEPHRINE-INDUCED CANINE CORONARY CYCLIC FLOW VARIATIONS